AI English summary of an SEC filing — figures as filed
The company said total sales rose 4.7% and 3.1% year over year in the 3-month and 9-month periods ended September 27, 2024, respectively. It said price increases contributed 1.8% and 2.0% to sales growth and are reflected in core sales growth.
Key points
AI summaryThe company said total sales rose 4.7% and 3.1% year over year in the 3-month and 9-month periods ended September 27, 2024, respectively. It said price increases contributed 1.8% and 2.0% to sales growth and are reflected in core sales growth.
Veralto said gross profit margin increased 200 basis points and 220 basis points in the 3-month and 9-month periods, respectively, and cited positive pricing actions as the main driver. It said operating profit margin rose 160 basis points, from 21.8% in the 3-month period to 23.4%, and 50 basis points, from 22.9% in the 9-month period to 23.4%.
The company said net interest expense was $27 million for the 3-month period and $85 million for the 9-month period. Operating cash flow for the 9-month period fell $110 million (16%) year over year, and the company cited cash interest payments of $137 million, cash tax payments of $209 million, and lower net income as factors.
The company said it held approximately $1.3 billion in cash and cash equivalents as of September 27, 2024, of which approximately $467 million was held in the United States and approximately $800 million was held outside the United States. Dividend payments totaled $67 million for the 9-month period, and it declared a quarterly dividend of $0.09 per share for Q3.
Key figures
Quarter ended September 27, 2024
- Revenue
- $1.3B
- Operating income
- $308M
- Net income
- $219M
- EPS
- $0.88
- Gross profit
- $783M
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Quarterly and 9-month sales rose on core growth and price increases
The company said total sales rose 4.7% and 3.1% year over year in the 3-month and 9-month periods ended September 27, 2024, respectively. It said price increases contributed 1.8% and 2.0% to sales growth and are reflected in core sales growth.
Source · Based on the MD&A text of the filing
Gross Profit and Operating Margin Changes
Veralto said gross profit margin increased 200 basis points and 220 basis points in the 3-month and 9-month periods, respectively, and cited positive pricing actions as the main driver. It said operating profit margin rose 160 basis points, from 21.8% in the 3-month period to 23.4%, and 50 basis points, from 22.9% in the 9-month period to 23.4%.
Source · Based on the MD&A text of the filing
Net Interest Expense and Operating Cash Flow Changes
The company said net interest expense was $27 million for the 3-month period and $85 million for the 9-month period. Operating cash flow for the 9-month period fell $110 million (16%) year over year, and the company cited cash interest payments of $137 million, cash tax payments of $209 million, and lower net income as factors.
Source · Based on the MD&A text of the filing
Cash Balance and Quarterly Dividend
The company said it held approximately $1.3 billion in cash and cash equivalents as of September 27, 2024, of which approximately $467 million was held in the United States and approximately $800 million was held outside the United States. Dividend payments totaled $67 million for the 9-month period, and it declared a quarterly dividend of $0.09 per share for Q3.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…